Effect of combining salmeterol and fluticasone on the progression of airway remodeling

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 8, 2002, Pages 1128-1134

  Vanacker, Nele J ^a   Palmans, Els ^a   Pauwels, Romain A ^a   Kips, Johan C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Asthma; Corticosteroids; Long acting agonists; Remodeling; Salmeterol

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COLLAGEN; CORTICOSTEROID; FIBRONECTIN; FLUTICASONE PROPIONATE; OVALBUMIN; PLACEBO; SALMETEROL; ANDROSTANE DERIVATIVE; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; DRUG DERIVATIVE; FLUTICASONE; GLUCOCORTICOID; SALBUTAMOL;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; EOSINOPHIL; GOBLET CELL; LUNG LAVAGE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRONCHUS; BROWN NORWAY RAT; CELL COUNT; CYTOLOGY; DRUG COMBINATION; IMMUNOLOGY; LEUKOCYTE COUNT; LUNG; MALE; METABOLISM; NEUTROPHIL; PATHOLOGY; RESPIRATORY TRACT ALLERGY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; CELL COUNT; COLLAGEN; DRUG COMBINATIONS; EOSINOPHILS; FIBRONECTINS; GLUCOCORTICOIDS; GOBLET CELLS; LEUKOCYTE COUNT; LUNG; MALE; NEUTROPHILS; OVALBUMIN; RATS; RATS, INBRED BN; RESPIRATORY HYPERSENSITIVITY;

EID: 0037108635     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200203-191OC     Document Type: Article

References (56)

1. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-224.
2. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
3. Kips JC, O'Connor BJ, Inman MD, Svensson K, Pauwels RA, O'Byrne PM. A long-term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000;161:996-1001.
4. 2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999;160:1493-1499.
5. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
6. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-899.
7. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, Testi R, Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997;155:1864-1871.
8. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043-1051.
9. Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991;104:672-676.
10. 2-agonists: inhibition of TNF-α release from human mast cells. J Allergy Clin Immunol 1997;100:825-831.
11. 2-Adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. Br J Pharmacol 2001;132:729-741.
12. Whelan CJ, Johnson M, Vardey CJ. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br J Pharmacol 1993;110:613-618.
13. Bolton PB, Lefevre P, McDonald DM. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways. Am J Respir Crit Care Med 1997;155:1428-1435.
14. Boulet LP, Chakir J, Milot J, Boutet M, Laviolette M. Effect of salmeterol on allergen-induced airway inflammation in mild allergic asthma. Clin Exp Allergy 2001;31:430-437.
15. 2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J 1999;14:275-282.
16. Boulet LP, Cartier A, Milot J, Cote J, Malo JL, Laviolette M. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids. Eur Respir J 1998;11:1091-1097.
17. 2-agonist. Am J Respir Crit Care Med 1996;154:1603-1607.
18. Mcivor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, Sears MR. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998;158:924-930.
19. Anderson GP. Interactions between corticosteroids and β-adrenergic agonists in asthma disease induction, progression, and exacerbation. Am J Respir Crit Care Med 2000;161:S188-S196.
20. 2-adrenergic receptor transcription in human lung. Am J Physiol Lung Cell Mol Physiol 1995;268:L41-L46.
21. Giannini D, Bacci E, Dente FL, Di Franco A, Vagaggini B, Testi R, Paggiaro P. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge. Chest 1999;115:629-634.
22. Palmans E, Kips JC, Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 2000;161:627-635.
23. Vanacker NJ, Palmans E, Kips JC, Pauwels RA. Fluticasone inhibits but does not reverse allergen induced structural airway changes. Am J Respir Crit Care Med 2001;163:674-679.
24. Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Fluticasone inhibits the progression of allergen-induced structural airway changes. Clin Exp Allergy 2002;32:914-920.
25. Sapienza S, Du T, Eidelman EH, Wang NS, Martin JG. Structural changes in the airways of sensitized Brown Norway rats after antigen challenge. Am Rev Respir Dis 1991;144:423-427.
26. Dente FL, Bancalari L, Bacci E, Bartoli ML, Carnevali S, Cianchetti S, Di Franco A, Giannini D, Vagaggini B, Testi R, et al. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax 1999;54:622-624.
27. Wallin A, Sandstrom T, Soderberg M, Howarth P, Lundback B, Della C-G, Wilson S, Judd M, Djukanovic R, Holgate S, et al. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1999;159:79-86.
28. Greiff L, Wollmer P, Andersson M, Svensson C, Persson CG. Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax 1998;53:1010-1013.
29. 2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001;164:117-121.
30. Lindqvist AE, Karjalainen EM, Laitinen LA, Kava T, Ahraja A, Pulkkinen M, Halme M, Laitinen A. Salmeterol (SLM), fluticasone propionate (FP) or disodium cromoglycate (DSCG) in the treatment of newly diagnosed asthma [abstract]. Am J Respir Crit Care Med 2001;163:A586.
31. Blyth DI, Pedrick MS, Savage TJ, Hessel EM, Fattah D. Lung inflammation and epithelial changes in a murine model of atopic asthma Am J Respir Cell Mol Biol 1996;14:425-438.
32. Haile S, Lefort J, Joseph D, Gounon P, Huerre M, Vargaftig BB. Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma. Am J Respir Cell Mol Biol 1999;20:891-902.
33. Ordonez CL, Khashayar R, Wong HH, Ferrando R, Wu R, Hyde DM, Hotchkiss JA, Zhang Y, Novikov A, Dolganov G, et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 2001;163:517-523.
34. Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162:6233-6237.
35. Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DCW, Nadel JA. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 2001;280:L134-L140.
36. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, Nicolaides NC. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000;22:649-656.
37. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM, Nadel JA. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 1999;96:3081-3086.
38. Kamachi A, Munakata M, Nasuhara Y, Nishimura M, Ohtsuka Y, Amishima M, Takahashi T, Homma Y, Kawakami Y. Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma. Thorax 2001;56:19-24.
39. Tan KS, Grove A, McLean A, Gnosspelius Y, Hall IP, Lipworth BJ. Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med 1997;156:28-35.
40. Peters MJ, Adcock IM, Brown CR, Barnes PJ. β-Adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 1995;289:275-281.
41. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999;274:1005-1010.
42. 2-agonist therapy in asthma. Am J Respir Crit Care Med 2001;164:923-932.
43. Hancox RJ, Stevens DA, Adcock IM, Barnes PJ, Taylor DR. Effects of inhaled β agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax 1999;54:488-492.
44. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen L. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997;156:951-958.
45. Kraft M, Lewis C, Pham D, Chu HW. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J Allergy Clin Immunol 2001;107:602-606.
46. Warshamana GS, Martinez S, Lasky JA, Corti M, Brody AR. Dexamethasone activates expression of the PDGF-α receptor and induces lung fibroblast proliferation. Am J Physiol 1998;18:L499-L507.
47. Silvestri M, Fregonese L, Sabatini F, Dasic G, Rossi GA. Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur Respir J 2001;18:139-145.
48. Beckett P, Shute J, Howarth P. Influence of salmeterol, fluticasone and the combination on fibroblast proliferation in vitro. Am J Respir Crit Care Med 2001;163:A473.
49. Hershman KM, Neely CM, Ameredes BT, Calhoun WJ. Regulation of extracellular matrix components by β agonist enantiomers: a possible role for airway remodeling. Am J Respir Crit Care Med 2001;163:A473.
50. Lambert RK, Codd SL, Alley MR, Pack RJ. Physical determinants of bronchial mucosal folding. J Appl Physiol 1994;77:1206-1216.
51. Bramley AM, Roberts CR, Schellenberg RR. Collagenase increases shortening of human bronchial smooth muscle in vitro. Am J Respir Crit Care Med 1995;152:1513-1517.
52. Shen X, Gunst SJ, Tepper RS. Effect of tidal volume and frequency on airway responsiveness in mechanically ventilated rabbits. J Appl Physiol 1997;83:1202-1208.
53. Wang ZL, Bramley AM, McNamara A, Pare PD, Bai TR. Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigs. Am J Respir Crit Care Med 1994;149:960-965.
54. 2 agonist exposure on airway remodeling in guinea pigs. Am J Respir Crit Care Med 1995;152:2097-2104.
55. 2 agonist, inhaled corticosteroid and their combination in the treatment of asthma. Thorax 1999;54:482-487.
56. Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harre E, Laubscher K, Linscott V, Ramsay CM, et al. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 1998;53:744-752.